Undervalued Small Caps With Insider Buying

Results

66

16 new

Smaller, under-the-radar companies, backed by insider buying, presenting a compelling opportunity for investors seeking undervalued gems.

66 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	GABC	US$51.11	0.6%	27.6%	US$1.9b	US$56.20	1.6	5.6%	2.4%	Banks
	ONT	US$17.50	16.0%	-37.7%	US$575.9m	US$18.60	0.8	145.1%	n/a	Commercial Services
	CBNA New	US$47.88	-0.3%	75.4%	US$318.2m	US$49.00	1.7	10.1%	n/a	Banks
	UNB	US$24.59	4.3%	-8.9%	US$119.8m	n/a	1.3	n/a	5.9%	Banks
	BMRC	US$28.52	-0.7%	22.7%	US$456.3m	US$31.80	1.1	102.5%	3.5%	Banks
	RCEL	US$8.01	68.6%	38.1%	US$251.1m	US$9.03	3.3	69.9%	n/a	Pharmaceuticals & Biotech
	SHBI	US$23.94	-0.7%	49.1%	US$801.3m	US$25.75	1.3	8.1%	2.3%	Banks
	BOTJ New	US$27.76	2.5%	95.7%	US$125.0m	n/a	1.5	n/a	1.4%	Banks
	SMWB	US$9.01	22.1%	7.4%	US$775.7m	US$10.80	2.7	117.0%	n/a	Software
	AUBN	US$26.50	0.4%	2.0%	US$92.7m	n/a	1.0	n/a	4.1%	Banks
	ILPT	US$9.15	6.3%	55.3%	US$605.4m	US$11.17	1.3	20.7%	4.4%	Real Estate
	ENOV	US$25.66	-2.5%	-11.0%	US$1.4b	US$41.25	0.6	145.8%	n/a	Healthcare
	KINS	US$19.47	-6.4%	30.2%	US$284.0m	US$21.50	8.0	16.7%	1.2%	Insurance
	ORN	US$9.68	-4.3%	43.6%	US$402.1m	US$15.32	108.8	74.8%	n/a	Capital Goods
	ANIK	US$21.17	5.0%	145.0%	US$294.8m	US$21.00	2.3	112.3%	n/a	Pharmaceuticals & Biotech
	ERII New	US$7.82	-10.4%	-46.0%	US$397.1m	US$9.33	26.0	27.1%	n/a	Capital Goods
	TRIN New	US$18.43	4.7%	14.4%	US$1.7b	US$18.50	12.3	20.8%	11.1%	Diversified Financials
	ALRS New	US$33.90	0.9%	54.0%	US$842.7m	US$35.40	30.6	40.6%	2.6%	Diversified Financials
	HPP New	US$14.50	7.9%	-21.5%	US$792.9m	US$16.75	0.3	62.0%	0%	Real Estate
	CMTV	US$40.73	1.7%	77.3%	US$221.8m	n/a	1.9	n/a	2.5%	Banks
	FRST	US$16.67	2.3%	47.5%	US$410.4m	US$18.63	1.0	-3.0%	2.4%	Banks
	KRO	US$8.65	5.1%	40.4%	US$904.7m	US$7.00	0.5	4.6%	2.3%	Materials
	PMTS	US$29.00	18.6%	84.5%	US$341.0m	US$32.50	24.3	46.8%	0%	Tech
	EMYB	US$22.44	-0.04%	40.9%	US$166.2m	n/a	1.3	n/a	2.1%	Banks

Page 1 of 2